Co-Diagnostics, Inc.
Co-Diagnostics, Inc. (CODX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
codx · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Co-Diagnostics, Inc. (CODX) measures how much investors pay for each dollar of the company's trailing earnings. CODX's current PE ratio of N/A is calculated by dividing its stock price of $5.06 by its TTM earnings per share of -$21.52.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2014 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Co-Diagnostics, Inc.You CODX | $6M | N/A | — | -$21.52 |
 Adagio Medical Holdings, Inc. ADGM | $11M | N/A | — | -$1.51 |
 Aethlon Medical, Inc. AEMD | $2M | N/A | — | -$85.77 |
 Allurion Technologies Inc. ALUR | $6M | N/A | — | -$0.38 |
 Dogwood Therapeutics, Inc. DWTX | $3M | N/A | — | -$4.17 |
 enVVeno Medical Corporation NVNO | $0M | N/A | — | -$33.06 |
 ProPhase Labs, Inc. PRPH | $0M | N/A | — | -$1.74 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-35.25 | — | |
2024-12-31 FY2024 | — | $-37.22 | — | |
2023-12-31 FY2023 | — | $-36.12 | — | |
2022-12-31 FY2022 | — | $-13.57 | — | |
2021-12-31 FY2021 | 7.03x | $38.09 | +20.2% | |
2020-12-31 FY2020 | 5.85x | $47.69 | — | |
2019-12-31 FY2019 | — | $-11.09 | — | |
2018-12-31 FY2018 | — | $-15.07 | — | |
2017-12-31 FY2017 | — | $-19.05 | — | |
2016-12-31 FY2016 | — | $-5.23 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Co-Diagnostics, Inc. (CODX) measures how much investors pay for each dollar of the company's trailing earnings. CODX's current PE ratio of N/A is calculated by dividing its stock price of $5.06 by its TTM earnings per share of -$21.52.
Frequently asked questions
CODX pe ratio · 6 questionsCODX's current PE ratio is N/A as of 2026-06-08, based on a stock price of $5.06 and TTM EPS of -$21.52. Data sourced from Financial Modeling Prep via CODX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Co-Diagnostics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08